Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Fax from Jane Kelly of PFC to Mike Palmer at the Department of Health, Scottish Office, including a document titled Factor VIII Concentrates manufactured by SNBTS (1974-1999).

Published on: 31 July, 2024

Background Notes on the Development of Hepatitis-Safe Factor 8 concentrates were produced by SNBTS.

Published on: 31 July, 2024

Michael Palmer wrote to the SNBTS National Director regarding the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.

Published on: 31 July, 2024

Dr Robert Perry wrote to Michael Palmer providing Background Notes on the Development of Hepatitis-Safe Factor VIII Concentrate by SNBTS.

Published on: 31 July, 2024

Professor Lowe and Professor Ludlam confirmed that it was normal practice within their centres to inform patients of the result of a test if they were found to be HCV positive.

Published on: 31 July, 2024

A briefing note from Michael Palmer to Susan Deacon, Minister for Health and Community Care, recommended that she emphasise to the Haemophilia Society that the Health Department was at arm's length from SNBTS, and that the Health Department aimed to report on its investigations within a month, with the Scottish Executive issuing its conclusions as soon as possible thereafter.

Published on: 31 July, 2024

Susan Deacon, Minister for Health and Community Care, assured the Haemophilia Society that issues raised by the Society would be investigated.

Published on: 31 July, 2024

Michael Palmer's report of the meeting on 14 September 1999 described how it became clear during the meeting that there were other strands of inquiry which the Haemophilia Society wished the Scottish Executive to pursue in its investigation, including the information provided to patients by clinicians. He reported that the Minister, Susan Deacon, assured the Society that these issues would also be investigated, although this would take longer than the expected month.

Published on: 31 July, 2024

First Minister of Scotland, Donald Dewar, expressed concern about the potential financial exposure should compensation for infection with Hepatitis C be paid.

Published on: 31 July, 2024

The Haemophilia Society expressed concern that some patients had been tested for Hepatitis C and not told the results and that in many cases there was delay in being told.

Published on: 31 July, 2024

Following a meeting with the Haemophilia Society Susan Deacon widened the Scottish Executive investigation to consider what information was provided to patients.

Published on: 31 July, 2024

An email sent by Karen Jackson on behalf of Donald Dewar expressed concern about the financial exposure to the Government of compensation payments.

Published on: 31 July, 2024

Susan Deacon's office advised that the matter was a PR exercise and compensation was unlikely to be paid.

Published on: 31 July, 2024

Karin Pappenheim wrote to Susan Deacon expressing the hope that communication between the Minister and the Haemophilia Society would continue and emphasised the importance of impartiality.

Published on: 31 July, 2024

The Scottish Executive investigation was expanded to consider information given to patients about the risks of contracting Hepatitis C/non-A non-B Hepatitis and the alleged delay in informing people with haemophilia that they were Hepatitis C positive after they had been tested.

Published on: 31 July, 2024

It was the expectation, as communicated to the Haemophilia Society, that the necessary evidence relating to the investigation would be examined within a month.

Published on: 31 July, 2024

William Wright wrote to Susan Deacon expressing concern at the lack of independence in a Health Department enquiry, which might involve officials being asked to criticise themselves "or other public servants whom they have worked closely with." He advocated an independent enquiry with a wider remit.

Published on: 31 July, 2024

Susan Deacon declined to undertake any wider investigation following a meeting with the Haemophilia Society.

Published on: 31 July, 2024

A meeting took place between SNBTS and the Haemophilia Society, attended also by Dr Keel.

Published on: 31 July, 2024

Bill Wright attended a meeting between SNBTS and the Haemophilia Society. He described "the surprise expressed by SNBTS representatives that someone could be infected as late as 1986 and us responding 'He is sitting here.'"

Published on: 31 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2051
  • Page 2052
  • Page 2053
  • Page 2054
  • Current page 2055
  • Page 2056
  • Page 2057
  • Page 2058
  • Page 2059
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.